Gentian Diagnostics AS - Asset Resilience Ratio

Latest as of December 2025: 40.97%

Gentian Diagnostics AS (GENT) has an Asset Resilience Ratio of 40.97% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read GENT current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Nkr105.93 Million

≈ $11.15 Million USD Cash + Short-term Investments

Total Assets

Nkr258.54 Million

≈ $27.21 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Gentian Diagnostics AS's Asset Resilience Ratio has changed over time. See GENT book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Gentian Diagnostics AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Gentian Diagnostics AS (GENT) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr105.93 Million	40.97%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr105.93 Million	40.97%

Asset Resilience Insights

Very High Liquidity: Gentian Diagnostics AS maintains exceptional liquid asset reserves at 40.97% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Gentian Diagnostics AS Industry Peers by Asset Resilience Ratio

Compare Gentian Diagnostics AS's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Sino Medical Sciences Technology In SHG:688108	Medical Devices	0.66%
Polynovo Ltd AU:PNV	Medical Devices	5.46%
Beijing Succeeder Technology Inc SHG:688338	Medical Devices	28.66%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Respiri Ltd AU:RSH	Medical Devices	0.46%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Duearity AB ST:DEAR	Medical Devices	145.62%

Annual Asset Resilience Ratio for Gentian Diagnostics AS (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Gentian Diagnostics AS.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	36.90%	Nkr84.74 Million ≈ $8.92 Million	Nkr229.66 Million ≈ $24.17 Million	+35.79pp
2023-12-31	1.11%	Nkr2.01 Million ≈ $211.62K	Nkr181.04 Million ≈ $19.05 Million	+0.01pp
2022-12-31	1.11%	Nkr2.08 Million ≈ $218.46K	Nkr187.79 Million ≈ $19.76 Million	-53.16pp
2021-12-31	54.27%	Nkr114.94 Million ≈ $12.09 Million	Nkr211.79 Million ≈ $22.29 Million	-12.88pp
2020-12-31	67.15%	Nkr157.99 Million ≈ $16.62 Million	Nkr235.26 Million ≈ $24.76 Million	-8.22pp
2019-12-31	75.37%	Nkr171.24 Million ≈ $18.02 Million	Nkr227.18 Million ≈ $23.91 Million	-1.49pp
2018-12-31	76.87%	Nkr198.31 Million ≈ $20.87 Million	Nkr257.98 Million ≈ $27.15 Million	+6.21pp
2017-12-31	70.65%	Nkr145.00 Million ≈ $15.26 Million	Nkr205.23 Million ≈ $21.60 Million	+10.40pp
2016-12-31	60.25%	Nkr74.09 Million ≈ $7.80 Million	Nkr122.96 Million ≈ $12.94 Million	--

pp = percentage points

About Gentian Diagnostics AS

OL:GENT Norway Medical Devices

Market Cap

$72.38 Million

Nkr687.84 Million NOK

Market Cap Rank

#20446 Global

#181 in Norway

Share Price

Nkr44.60

Change (1 day)

+9.85%

52-Week Range

Nkr37.60 - Nkr64.80

All Time High

Nkr86.00